Associate Director, Corporate Strategy

Lupin Somerset; Naples (FL); On-site; USD 130,000 - 170,000; Full time

Job summary

Lupin Somerset is seeking an experienced Associate Director for its Corporate Strategy team in Naples, FL. This role requires a strategic and analytical individual with over 8 years of relevant experience in management consulting and corporate strategy within the life sciences sector.

The successful candidate will shape enterprise strategies across specialty pharmaceutical products and biosimilars, working closely with the Executive Leadership Team to maximize long-term value.

Collaboration with various departments to align strategy across development, regulatory pathways, and commercialization is essential. A strong background in strategic analysis and leading cross-functional teams is required.

Qualifications

• 8+ years in management consulting or strategy within pharmaceuticals or biotech.
• 5+ years advising on growth strategies in specialty and complex therapeutic areas.
• Proven ability to translate complex insights into actionable recommendations.

Responsibilities

• Support strategic initiatives for Specialty Pharma and Biosimilars.
• Lead strategic analyses for portfolio prioritization and lifecycle management.
• Drive development of executive-ready presentations and board materials.

Skills

Analytical skills

Strategic thinking

Leadership

Collaboration

Problem-solving

Education

MBA or Master’s in Business or Life Sciences

Bachelor’s degree in a science-related discipline

Tools

Analytics tools

Presentation tools

Job description

Overview

This is an onsite role based out of our Naples, FL location.

We are seeking a highly skilled Associate Director to join our Corporate Strategy team. The ideal candidate will be a strategic, analytical, and results-driven professional with 8+ years of experience in management consulting and/or corporate strategy within the life sciences sector, including demonstrated experience across Specialty Pharmaceuticals and Biosimilars, with a strong focus on Respiratory, Neuroscience, and Ophthalmology therapeutic areas.

The successful candidate will bring deep experience shaping and executing enterprise and therapeutic-area strategies across innovative specialty products and complex biosimilar portfolios, supporting growth objectives for pharmaceutical and biotechnology organizations operating in highly competitive, regulated, and access-driven markets.

In this role, you will play an active role in shaping the company’s strategic agenda in direct collaboration with the Sr Director, Corporate Strategy and Executive Leadership Team, leveraging market intelligence, competitive and pipeline insights, financial analysis, and cross-functional collaboration to guide executive decision-making and maximize long-term enterprise value across specialty brands and biosimilar franchises.

Responsibilities

• Support enterprise-wide and therapeutic-area‑specific strategic initiatives that address mission‑critical questions and position the organization for long‑term success across Specialty Pharma and Biosimilars, including Respiratory, Neuroscience, and Ophthalmology.
• Lead strategic analyses related to portfolio prioritization, lifecycle management, indication expansion, and pipeline trade‑offs, spanning innovative specialty assets and biosimilar development programs.
• Develop strategies addressing biosimilar‑specific dynamics, including:
  • Market entry and sequencing
  • Competitive landscape and reference product strategy
  • Pricing, contracting, and access considerations
  • Portfolio optimization and capital allocation
• Partner closely with R&D, Medical Affairs, Market Access, Commercial, and Manufacturing to align strategy across clinical development, regulatory pathways, supply considerations, and commercialization models.
• Support strategy development for launch planning, post‑LOE strategies, and competitive positioning in specialty and biosimilar markets characterized by payer sensitivity, formulary competition, and evolving policy landscapes.
• Work in close partnership with the CEO, Executive Leadership Team (ELT), and senior functional leaders to deliver high‑quality, insight‑driven project deliverables informing investment, growth, and risk decisions.
• Drive development of executive‑ready presentations, board materials, and strategic narratives that translate complex clinical, regulatory, market access, and financial inputs into clear recommendations.
• Help communicate enterprise and therapeutic‑area strategies across the organization, ensuring clarity, alignment, and disciplined execution.

Qualifications

• MBA or Master’s degree in Business, Life Sciences, Public Health, or a related field (preferred: top‑tier business school)
• Bachelor’s degree in a science‑related discipline preferred (e.g., Biology, Chemistry, Pharmacology)
• 8+ years of cumulative experience in management consulting and/or in‑house strategy, corporate development, or business planning within the pharmaceutical or biotech industry.
• Management Consulting Experience:
  • 5+ years advising pharmaceutical clients on growth strategies, portfolio strategy, product launches, pipeline prioritization, and biosimilar market assessments, with exposure to specialty and complex therapeutic areas.
• In‑house Strategy or Corporate Development Experience:
  • Experience at a mid‑to‑large pharmaceutical or biotechnology company supporting C‑level initiatives, long‑range planning, M&A, licensing, or biosimilar portfolio assessments.
• Proven ability to synthesize clinical, regulatory, commercial, market access, and financial insights into actionable recommendations that influence enterprise‑wide decisions.
• Track record of leading cross‑functional teams on initiatives such as go‑to‑market planning, therapeutic‑area strategy, biosimilar commercialization strategy, and enterprise transformation.

Skills and Capabilities

• Strong business acumen with a deep understanding of the pharmaceutical value chain, including R&D, regulatory pathways (innovator and biosimilar), medical strategy, market access, and commercialization.
• Solid understanding of biosimilar market dynamics, including pricing and contracting strategies, payer behavior, interchangeability considerations, and competitive launch sequencing.
• Strong grasp of specialty market dynamics, including specialist engagement models, complex patient journeys, and access and reimbursement challenges.
• Exceptional analytical, problem‑solving, and strategic storytelling skills, with the ability to influence senior executives.
• Highly collaborative and effective in matrixed, global environments.
• Thrives in fast‑paced settings with evolving priorities and high visibility.
• Proficiency with modern analytics, presentation tools, and emerging AI‑enabled strategy and insight‑generation technologies.

Lupin is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, national origin, gender, religion, age, disability, veteran’s status, or any other classification as required by applicable law.